Epstein - Barr virus is an important cause Hodgkin's Disease, Lymphomas, and Lymphoproliferative Diseases, particularly in people with HIV infection and other immune- compromised states. The EBV oncoprotein Latent Membrane Protein 1 transforms B-cells through 2 essential signaling domains for B cell growth: Transformation effect site 1, which activates non- canonical NFkB and site 2, which activates canonical NFkB. Both NFkB pathways are necessary for infected cell growth and survival. To discover key components of LMP1 affected NFkB pathways, our AIMS are to: (1) Characterize key B-cell proteins required for LMP1 TES2 canonical NFkB activation for their role in TRAF6 and IKK activation, NEMO ubiquitination, and nuclear RelA phosphorylation. Candidates for missing kinases, phosphatases, E3 ligases, and scaffolds have been identified through a genome wide siRNA screen in 293 cells and will be evaluated in B cells. (2) Key B-cell proteins required for LMP1 TES1 non-canonical NFkB activation will be identified.
This aim will focus on unique LMP1 effects through TRAFs, will employ LMP1 and TRAF genetic analyses and will identify novel cell proteins critical for LMP1-mediated non-canonical NFkB activation. (3) Identify combinations of AIM 1 and 2 target proteins knockdowns that create synthetic lethal effects, when both are depleted from EBV-transformed B cells.
AIM3 experiments exploit what we learn in AIMS 1 and 2 to identify the Achilles'Heel of EBV-associated lymphomas. NFkB small molecule inhibitors that are not specific for LMP1-mediated NFkB activation will likely be limited by side-effects, including inhibition of critical immune responses. These studies specifically address NCI goals outlined in PA10-290 by determining the mechanism by which EBV affects tumor promotion and progression, by discovering novel targets for rational drug discovery for the treatment of persons afflicted with AIDS-defining malignancies, and by using combinatorial genomic methodologies to further development of therapeutic agents. Our discoveries will elucidate new key targets in NFkB activation and more broadly advance priority target-based tool compound discovery.

Public Health Relevance

Epstein - Barr virus infects more than 96% of the population world-wide and is a significant cause of cancers in immuno-compromised people. With very few proteins, EBV circumvents the normal controls that prevent cancer. Our studies evaluate EBV effects on cell signaling pathways, reveal mechanisms of cancer etiology, and identify therapeutic targets.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA085180-11A1
Application #
8263567
Study Section
AIDS-associated Opportunistic Infections and Cancer Study Section (AOIC)
Program Officer
Daschner, Phillip J
Project Start
2000-09-20
Project End
2016-11-30
Budget Start
2011-12-01
Budget End
2012-11-30
Support Year
11
Fiscal Year
2012
Total Cost
$701,405
Indirect Cost
$308,461
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Zhao, Bo; Barrera, Luis A; Ersing, Ina et al. (2014) The NF-?B genomic landscape in lymphoblastoid B cells. Cell Rep 8:1595-606
Chen, Ya-Lin; Liu, Cheng-Der; Cheng, Chi-Ping et al. (2014) Nucleolin is important for Epstein-Barr virus nuclear antigen 1-mediated episome binding, maintenance, and transcription. Proc Natl Acad Sci U S A 111:243-8
Hadweh, Paul; Habelhah, Hasem; Kieff, Elliott et al. (2014) The PP4R1 subunit of protein phosphatase PP4 targets TRAF2 and TRAF6 to mediate inhibition of NF-*B activation. Cell Signal 26:2730-2737
Jiang, Sizun; Willox, Bradford; Zhou, Hufeng et al. (2014) Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A. Proc Natl Acad Sci U S A 111:421-6
Hansel, Nadia N; Ruczinski, Ingo; Rafaels, Nicholas et al. (2013) Genome-wide study identifies two loci associated with lung function decline in mild to moderate COPD. Hum Genet 132:79-90
Ersing, Ina; Bernhardt, Katharina; Gewurz, Benjamin E (2013) NF-*B and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1. Viruses 5:1587-606
Liu, Cheng-Der; Cheng, Chi-Ping; Fang, Jia-Shih et al. (2013) Modulation of Epstein-Barr virus nuclear antigen 2-dependent transcription by protein arginine methyltransferase 5. Biochem Biophys Res Commun 430:1097-102
Gewurz, Benjamin E; Towfic, Fadi; Mar, Jessica C et al. (2012) Genome-wide siRNA screen for mediators of NF-*B activation. Proc Natl Acad Sci U S A 109:2467-72
Gewurz, Benjamin E; Mar, Jessica C; Padi, Megha et al. (2011) Canonical NF-kappaB activation is essential for Epstein-Barr virus latent membrane protein 1 TES2/CTAR2 gene regulation. J Virol 85:6764-73
Zhao, Bo; Zou, James; Wang, Hongfang et al. (2011) Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth. Proc Natl Acad Sci U S A 108:14902-7

Showing the most recent 10 out of 30 publications